Omamalin, Justine G.

HRN: 22-86-79  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2023
AMPICILLIN 1GM (VIAL)
04/15/2023
04/22/2023
IV
340mg
Q12hrs
PCAP Severe
Waiting Final Action 
04/15/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
04/15/2023
04/22/2023
IV
34mg
Q24hrs
PCAP Severe
Waiting Final Action 
04/15/2023
CEFTRIAXONE 1G (VIAL)
04/15/2023
04/22/2023
IV
670mg
Q24
PCAP Severe
Waiting Final Action 
04/21/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
04/21/2023
04/28/2023
IV
2ml
Q12h
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: